Approximately 60 derivatives of anguidin were prepared for evaluation of antitumor activities. Positions 3, 4, 8-10, and 15 were modified, and the resultant derivatives were screened against P-388 leukemia. It was found that introduction of the C3-keto and C3, Cgdiketo groups markedly improved the antileukemic activity, whereas epoxidation of the CW 1 0 double bond or oxidation of the C15 position diminished its activity. Selected ...